biospecimen__admin__batch_number	100.78.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	1FEEFCC1-7DEC-4B94-9951-0B803F1888B6
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-BC-A10Z-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-BC-A10Z-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-BC-A10Z-01A
biospecimen__bio__biospecimen_barcode_bottom	0108433609
biospecimen__bio__day_of_creation	22
biospecimen__bio__day_of_shipment	01
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	11
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-BC-A10Z.427BA175-823D-4C68-B659-D53CFEB5EA45.pdf
biospecimen__bio__plate_column	2
biospecimen__bio__plate_id	A130
biospecimen__bio__plate_row	B
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2010
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-BC-A10Z
biospecimen__shared__patient_id	A10Z
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	8C004128-E347-4A9A-B975-0635F19B8DFD
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	3.1
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.6
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.1
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.2
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	10
clinical__chol_lihc_shared__fetoprotein_outcome_value	779
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	440
clinical__chol_lihc_shared__prothrombin_time_result_value	0.9
clinical__chol_lihc_shared__specimen_collection_method_name	Extended Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	62
clinical__clin_shared__bcr_followup_barcode	TCGA-BC-A10Z-F9962
clinical__clin_shared__bcr_followup_uuid	D5A4C022-45D6-4F96-BE1E-2BD1D7DDE1AC
clinical__clin_shared__cancer_first_degree_relative	1
clinical__clin_shared__day_of_form_completion	4
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__month_of_form_completion	4
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	260
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2011
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2003
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__nte__new_neoplasm_event_type	No New Tumor Event
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	df09f61b-7270-4419-9809-1a7c52afb41b
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-BC-A10Z-01A-11R-A130-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	b83e551a-2887-4088-94c5-dc124aaf377e
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.86
gdc__analytes__analyte_id	c8b21a17-4079-4f91-a3ed-c2ca4439b38b
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	709f1e4d-f5e8-4a0b-8254-23f037f4bae7
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:54:50.037061-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	bff2643f-6fb9-556c-9bcb-b6a9f0d91f69
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1941
gdc__demographic__year_of_death	2003
gdc__diagnoses__age_at_diagnosis	22913
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-22913.0
gdc__diagnoses__days_to_death	34.0
gdc__diagnoses__diagnosis_id	bb23023f-782a-51c3-bb36-ed7952793897
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__exposure_id	8b7fcab9-fe9f-569c-8a6f-c0f58a91a8f5
gdc__exposures__weight	79.0
gdc__file_id	9706f211-7517-46b6-ad09-176b595fefb2
gdc__file_name	b9c3eb5c-c32b-49f8-8842-b7c4bb3ac617.mirbase21.mirnas.quantification.txt
gdc__file_size	50374
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	c564d09638a409e768c3cad22d92f35a
gdc__portions__is_ffpe	false
gdc__portions__portion_id	6ebfd684-8349-4d50-8b01-23d50f1f5baa
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	2652
gdc__samples__initial_weight	160.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	427BA175-823D-4C68-B659-D53CFEB5EA45
gdc__samples__sample_id	a758e425-e4f9-4b71-86f0-f82f4331055d
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	5.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	15.0
gdc__slides__percent_tumor_cells	80.0
gdc__slides__percent_tumor_nuclei	85.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	146fde04-6d55-4072-ac45-20bd4ebdedc6
gdc__submitter_id	mirna_swap_dr11_420_MirnaExpression1811d54a-a221-4f87-8226-372bd0579838_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	BC
gdc__tissue_source_site__name	UNC
gdc__tissue_source_site__tissue_source_site_id	735fda57-1a46-5afd-a1c0-99af9115c0af
gdc__treatments__treatment_id	8f281926-ea8f-552c-bdd2-5be8ab9604d8
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:11:35.417+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/df09f61b-7270-4419-9809-1a7c52afb41b-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/df09f61b-7270-4419-9809-1a7c52afb41b-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129745
manually_curated__local_md5	ad10b2e98dd8faa8c0dc53e742295547
manually_curated__opengdc_download_date	2018-10-16T17:12:37.000529+02:00
manually_curated__opengdc_file_md5	de10a3fed75c58deaa40f0a40771720e
manually_curated__opengdc_file_size	50373
manually_curated__opengdc_id	df09f61b-7270-4419-9809-1a7c52afb41b-meq
manually_curated__origin_file_size	129745
manually_curated__origin_last_modified_date	Tue Oct 16 17:57:00 CEST 2018
manually_curated__origin_md5	ad10b2e98dd8faa8c0dc53e742295547
manually_curated__tissue_status	tumoral
